We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

64 hedge funds and large institutions have $141M invested in Alimera Sciences in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,300% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $9K

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

0% more funds holding

Funds holding: 6464 (0)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

6% less capital invested

Capital invested by funds: $151M → $141M (-$9.7M)

Holders
64
Holders Change
Holders Change %
0%
% of All Funds
1.72%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
8
Increased
26
Reduced
16
Closed
8
Calls
$1.03M
Puts
$9K
Net Calls
+$1.02M
Net Calls Change
+$1.13M
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Scale Management
California
$20.6M -$369K -5,344 -2%
DM
2
Deerfield Management
New York
$20.4M
NRC
3
North Run Capital
Massachusetts
$15.9M +$2.18M +31,551 +16%
PVMCI
4
Polaris Venture Management Co IV
Massachusetts
$14.5M
PAI
5
Palo Alto Investors
California
$13.9M
GPP
6
Great Point Partners
Connecticut
$7.76M -$223K -3,226 -3%
O
7
OrbiMed
New York
$6.92M
BFA
8
BlackRock Fund Advisors
California
$6.14M +$130K +1,885 +2%
PVI
9
Pura Vida Investments
New York
$6M +$588K +8,521 +11%
ACP
10
Acuta Capital Partners
California
$4.49M -$370K -5,366 -8%
Vanguard Group
11
Vanguard Group
Pennsylvania
$4.05M +$103K +1,499 +3%
SCM
12
Suffolk Capital Management
New York
$2.96M +$364K +5,274 +14%
Deutsche Bank
13
Deutsche Bank
Germany
$2.9M +$162K +2,350 +6%
Goldman Sachs
14
Goldman Sachs
New York
$1.64M +$1.44M +20,829 +714%
State Street
15
State Street
Massachusetts
$1.4M +$2.9K +42 +0.2%
Millennium Management
16
Millennium Management
New York
$1.36M -$515K -7,469 -28%
Northern Trust
17
Northern Trust
Illinois
$1.24M -$22.3K -323 -2%
PI
18
Putnam Investments
Massachusetts
$1.1M +$1.09M +15,866 New
BIT
19
BlackRock Institutional Trust
California
$907K -$97.8K -1,418 -10%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$709K +$49K +711 +7%
BCM
21
Bridgeway Capital Management
Texas
$697K
Bank of New York Mellon
22
Bank of New York Mellon
New York
$533K +$12.8K +186 +2%
BIM
23
BlackRock Investment Management
Delaware
$516K +$166K +2,411 +48%
TCIM
24
TIAA CREF Investment Management
New York
$478K +$36.6K +530 +8%
HVC
25
Healthcare Value Capital
New Jersey
$461K

ALIM Hedge Fund Activity: Q2 2015 in Review

64 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2015, worth a combined $141M — down 6.4% from $151M a quarter earlier.

Fund positioning in ALIM was balanced in Q2 2015: 8 funds opened new positions, 8 closed out, 26 added to existing stakes and 16 trimmed.

The largest buyer was North Run Capital, adding an estimated $2.18M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.16M sold.

  • 64 institutional investors held Alimera Sciences (ALIM) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $141M of Alimera Sciences stock for Q2 2015, down 6.4% quarter-over-quarter.
  • 8 funds opened new Alimera Sciences positions in Q2 2015 and 8 closed out, a net change of 0 holders.
  • The largest Alimera Sciences buyer in Q2 2015 was North Run Capital, an estimated $2.18M added.
  • The largest Alimera Sciences seller in Q2 2015 was Perceptive Advisors, an estimated $1.16M sold.

Based on aggregated 13F filings for Q2 2015.